secwatch.observer — SEC 8-K summary
======================================

Issuer:     FibroBiologics, Inc. (FBLG)
CIK:        0001958777
Form:       8-K
Filed at:   2026-04-02T23:59:59+00:00
Accession:  0001193125-26-140044
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

FibroBiologics closes $3M public offering of common stock and warrants at $1.32/unit
--------------------------------------------------------------------------------

- Offering of 2,272,728 shares (or pre-funded warrants) plus warrants, combined price $1.32/unit; net proceeds ~$2.5M after fees.
- Warrants exercise price $1.32, exercisable only after stockholder approval; if fully cash-exercised, additional $3M proceeds possible.
- Pre-funded warrants exercise price $0.00001, no expiration; beneficial ownership cap 9.99%.
- Placement agent H.C. Wainwright received 7.0% cash fee, 1.0% management fee, and 159,091 placement agent warrants at $1.65.
- Lock-up: insiders 30 days; company restricted from further equity issuance for 30 days and no variable-rate transactions for one year.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1958777/000119312526140044/0001193125-26-140044-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1958777/000119312526140044/fblg-20260331.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-140044

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer